NCT04539223 - A Study of Evolocumab on Carotid Artery Atherosclerotic Plaque Morphology Prior to Carotid EndArterectomy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 28, 2020

Primary Completion Date

April 30, 2022

Study Completion Date

May 31, 2022

Conditions

Carotid Artery StenosisAsymptomatic Carotid Artery Stenosis

Interventions

DRUG

Evolocumab

Autoinjector 1-mL deliverable volume of 140 mg/mL

Trial Locations (3)

RECRUITING

North York Diagnostic and Cardiac Centre, North York

RECRUITING

East Toronto Vascular Clinic, Toronto

RECRUITING

St. Michael's Hospital, Toronto